Day 2 - 3 September 2022
|
TIME
|
TOPIC
|
PRESENTER
|
MODERATOR
|
|
8:30am to 9am
|
Registration
|
|
Session
3
|
Poster /Oral Presentation
|
|
9am to 9:15am
|
Oncotype DX RS Correlation with Clinicopathologic Risk Factors and Chemotherapy: Follow-up based on TAILORx study
|
Dr. Faroug Salih Ali
|
Dr. Mufid El Mistiri
Dr. Anas Ahmad
Ms. Nima Ali
Dr. Cicy Jacob
Dr. Ahlam Yousef
|
|
9:15am to 9:30am
|
Poster Medical Oncology
|
Dr. Ashraf Awad
|
|
9:30am to 9:45am
|
Breast Cancer in Elderly Qatar Experiences
|
Dr. Salman Husain M. Al Shaibani
|
|
9:45am to 10am
|
Psychosocial Interventions for Breast Cancer Patients and Their Families: Sneaking Through Traditional Taboos
|
Dr. Abdelhamid Afana
|
|
10am to 10:15am
|
Pembrolizumab in neoadjuvant and adjuvant triple negative breast cancer.. Should we consider?
|
Dr. Hebatallah Afifi
|
|
10:15am to 10:30am
|
Exploring the Complex Care Needs of Breast Cancer Patients: Care Coordination by Clinical Nurse Specialist
|
Ms. Gulfama Abidullah Muhammad
|
|
10:30am to 10:45am
|
Enhancing Communication Between Medical and Surgical Services in Breast Cancer.
|
Ms. Wafaa Shehada
|
|
10:45am - 11:00am
|
Precision Medicine Clinical Case Studies
|
Dr. Shaza Bek
|
|
11:00am - 11:15am
|
Dr. Ahmed Abdelhadi
|
|
11:15am - 11:30am
|
Dr. Shaima Abdelrahim
|
|
11am to 12pm
|
Prayer
|
|
Session
4
|
Satellite Symposia
|
|
12pm to 12:30pm
|
Recent Updates About De-Escalation of Chemotherapy in BC.
|
Dr. Nadia Harbeck
sponsored by Roche
|
Dr. Francois Calaud
Dr. Hind El-Malik
|
|
12:30pm to 1pm
|
Update in Breast Cancer Management
|
Dr. Hamdy A. Azim
sponsored by MSD
|
|
1pm to 1:30pm
|
Updates in Management of HER2-ve MBC
|
Prof. Peter Fasching sponsored by AstraZeneca
|
|
1:30pm to 1:45pm
|
Panel Discussion
|
All
|
|
|
1:45pm to 2pm
|
Closing Remarks Dr. Salha Bujassoum
|
|
.